These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17601370)

  • 1. Immunology of stem cells and cancer stem cells.
    Yang XF
    Cell Mol Immunol; 2007 Jun; 4(3):161-71. PubMed ID: 17601370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.
    Mimeault M; Hauke R; Batra SK
    Clin Pharmacol Ther; 2007 Sep; 82(3):252-64. PubMed ID: 17671448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing stem cells and dendritic cells for novel therapies.
    Markowicz S
    Acta Pol Pharm; 2008; 65(6):625-32. PubMed ID: 19172843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte transplantation: waiting for stem cells.
    Haridass D; Narain N; Ott M
    Curr Opin Organ Transplant; 2008 Dec; 13(6):627-32. PubMed ID: 19060554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation tolerance in an age of induced pluripotency.
    Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation.
    Boyd AS; Higashi Y; Wood KJ
    Adv Drug Deliv Rev; 2005 Dec; 57(13):1944-69. PubMed ID: 16289432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of stem cells in kidney disease.
    Chhabra P; Brayman KL
    Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclinical safety strategies for stem cell therapies.
    Sharpe ME; Morton D; Rossi A
    Toxicol Appl Pharmacol; 2012 Aug; 262(3):223-31. PubMed ID: 22617430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S; Nostro MC; Kattman SJ; Keller GM
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced survival of bone-marrow-derived pluripotent stem cells in an animal model of auditory neuropathy.
    Matsuoka AJ; Kondo T; Miyamoto RT; Hashino E
    Laryngoscope; 2007 Sep; 117(9):1629-35. PubMed ID: 17632425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
    Crook JM; Kobayashi NR
    J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell-based therapy in gastroenterology and hepatology.
    Piscaglia AC; Novi M; Campanale M; Gasbarrini A
    Minim Invasive Ther Allied Technol; 2008; 17(2):100-18. PubMed ID: 18465445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of mesenchymal stem cell therapy.
    Dazzi F; Horwood NJ
    Curr Opin Oncol; 2007 Nov; 19(6):650-5. PubMed ID: 17906466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for stem cell-based therapy.
    Daley GQ; Scadden DT
    Cell; 2008 Feb; 132(4):544-8. PubMed ID: 18295571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells and nuclear reprogramming.
    Saric T; Hescheler J
    Minim Invasive Ther Allied Technol; 2008; 17(2):64-78. PubMed ID: 18465442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
    Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
    J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines.
    Drukker M
    Semin Immunol; 2008 Apr; 20(2):123-9. PubMed ID: 18160306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent human stem cell lines: what we can learn about cancer initiation.
    Werbowetski-Ogilvie TE; Bhatia M
    Trends Mol Med; 2008 Aug; 14(8):323-32. PubMed ID: 18635398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell applications in intervertebral disc repair.
    Hiyama A; Mochida J; Sakai D
    Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54(1):24-32. PubMed ID: 18954548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.